Wu; Liangxing
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wu; Liangxing.The latest application filed is for "spirocyclic lactams as jak2 v617f inhibitors".
Company Profile
89.67.142
- Wu; Liangxing - Wilmington DE
- Wu; Liangxing - Upper Darby PA
- Wu; Liangxing - College Station TX
Patent Activity
| Patent | Date |
|---|---|
| Tricyclic amine compounds as CDK2 inhibitors Grant 11,447,494 - Ye , et al. September 20, 2 | 2022-09-20 |
| Tricyclic amine compounds as CDK2 inhibitors Grant 11,440,914 - Ye , et al. September 13, 2 | 2022-09-13 |
| Spirocyclic Lactams As Jak2 V617f Inhibitors App 20220281887 - Shepard; Stacey ; et al. | 2022-09-08 |
| Imidazopyridazine and imidazopyridine compounds and uses thereof Grant 11,427,592 - Pan , et al. August 30, 2 | 2022-08-30 |
| Heteroaryl amide compounds as sting activators Grant 11,427,597 - Wu , et al. August 30, 2 | 2022-08-30 |
| Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors Grant 11,427,567 - Ye , et al. August 30, 2 | 2022-08-30 |
| Heterocyclic compounds as immunomodulators Grant 11,414,433 - Wu , et al. August 16, 2 | 2022-08-16 |
| Heterocyclic compounds as immunomodulators Grant 11,407,749 - Wu , et al. August 9, 2 | 2022-08-09 |
| Pyrido[3,2-d]pyrimidine compounds as immunomodulators Grant 11,401,279 - Li , et al. August 2, 2 | 2022-08-02 |
| Heterocyclic compounds as LSD1 inhibitors Grant 11,401,272 - He , et al. August 2, 2 | 2022-08-02 |
| Combination Therapy Comprising A2a/a2b Inhibitors, Pd-1/pd-l1 Inhibitors, And Anti-cd73 Antibodies App 20220233529 - Wang; Hui ; et al. | 2022-07-28 |
| Substituted spiro[cyclopropane-1,5'-pyrrolo[2,3-d]pyrimidin]-6'(7'h)-ones as CDK2 inhibitors Grant 11,384,083 - Sokolsky , et al. July 12, 2 | 2022-07-12 |
| Heterocyclic Compounds As Immunomodulators App 20220213090 - Wu; Liangxing ; et al. | 2022-07-07 |
| Deazaguaine Compounds As Jak2 V617f Inhibitors App 20220213108 - Buesking; Andrew W. ; et al. | 2022-07-07 |
| Heterocyclic Compounds As Immunomodulators App 20220194931 - Wu; Liangxing ; et al. | 2022-06-23 |
| Tricyclic Urea Compounds As Jak2 V617f Inhibitors App 20220169649 - Ai; Yanran ; et al. | 2022-06-02 |
| Heterocyclic compounds as immunomodulators Grant 11,339,149 - Wu , et al. May 24, 2 | 2022-05-24 |
| Fused Pyrazine Derivatives As A2a / A2b Inhibitors App 20220135570 - Wang; Xiaozhao ; et al. | 2022-05-05 |
| Heterocyclic Compounds As Immunomodulators App 20220089588 - Wu; Liangxing ; et al. | 2022-03-24 |
| Tricyclic Heterocyclic Compounds As Sting Activators App 20220073509 - Wu; Liangxing ; et al. | 2022-03-10 |
| Tricyclic Urea Compounds As Jak2 V617f Inhibitors App 20220064165 - Liu; Kai ; et al. | 2022-03-03 |
| Heteroaryl Amide Compounds As Sting Activators App 20220056049 - Wu; Liangxing ; et al. | 2022-02-24 |
| Cyclopropylamines as LSD1 inhibitors Grant 11,247,992 - Wu , et al. February 15, 2 | 2022-02-15 |
| Pyrazolopyrimidine Compounds And Uses Thereof App 20220017521 - Vechorkin; Oleg ; et al. | 2022-01-20 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20220009921 - Lu; Liang ; et al. | 2022-01-13 |
| Dihydropyrido[2,3-d]pyrimidinone Compounds As Cdk2 Inhibitors App 20220009923 - Sokolsky; Alexander ; et al. | 2022-01-13 |
| Tricyclic Pyridone Compounds As Jak2 V617f Inhibitors App 20220002299 - Liu; Kai ; et al. | 2022-01-06 |
| Pyrrolotriazine Compounds As Jak2 V617f Inhibitors App 20210395257 - Yu; Zhiyong ; et al. | 2021-12-23 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20210395246 - Sun; Yaping ; et al. | 2021-12-23 |
| Naphthyridinone Compounds As Jak2 V617f Inhibitors App 20210395251 - Shepard; Stacey ; et al. | 2021-12-23 |
| Imidazopyridazine Compounds And Uses Thereof App 20210388003 - Pan; Jun ; et al. | 2021-12-16 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20210380587 - Wu; Liangxing ; et al. | 2021-12-09 |
| Heterocyclic Compounds As Immunomodulators App 20210380584 - Wu; Liangxing ; et al. | 2021-12-09 |
| Heterocyclic Compounds As Immunomodulators App 20210363137 - Wu; Liangxing ; et al. | 2021-11-25 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 11,173,162 - Sokolsky , et al. November 16, 2 | 2021-11-16 |
| Heterocyclic Compounds As Immunomodulators App 20210347771 - Wu; Liangxing ; et al. | 2021-11-11 |
| Fused pyrimidine derivatives as A2A / A2B inhibitors Grant 11,168,089 - Wang , et al. November 9, 2 | 2021-11-09 |
| Fused pyrazine derivatives as A2A / A2B inhibitors Grant 11,161,850 - Wang , et al. November 2, 2 | 2021-11-02 |
| Tricyclic Heteroaryl Compounds As Sting Activators App 20210332067 - Wu; Liangxing ; et al. | 2021-10-28 |
| Cyclopropylamines as LSD1 inhibitors Grant 11,155,532 - Wu , et al. October 26, 2 | 2021-10-26 |
| Heterocyclic Compounds As Immunomodulators App 20210317139 - Xiao; Kaijiong ; et al. | 2021-10-14 |
| Heterocyclic compounds as immunomodulators Grant 11,124,511 - Wu , et al. September 21, 2 | 2021-09-21 |
| Pyrazolopyrimidine compounds and uses thereof Grant 11,111,247 - Vechorkin , et al. September 7, 2 | 2021-09-07 |
| Tricyclic Compounds As Inhibitors Of Kras App 20210269434 - Wang; Xiaozhao ; et al. | 2021-09-02 |
| Fused Pyrimidine Derivatives As A2a / A2b Inhibitors App 20210261555 - Wang; Xiaozhao ; et al. | 2021-08-26 |
| Cd73 Inhibitor And A2a/a2b Adenosine Receptor Inhibitor Combination Therapy App 20210230294 - Nastri; Horacio G. ; et al. | 2021-07-29 |
| Spiro Compounds As Inhibitors Of Kras App 20210230162 - Zhao; Le ; et al. | 2021-07-29 |
| Heterocyclic Compounds As Immunomodulators App 20210221819 - Li; Jingwei ; et al. | 2021-07-22 |
| Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors Grant 11,066,404 - Sokolsky , et al. July 20, 2 | 2021-07-20 |
| Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors App 20210205311 - Wang; Hui ; et al. | 2021-07-08 |
| Substituted tricyclic compounds as FGFR inhibitors Grant 11,053,246 - Wu , et al. July 6, 2 | 2021-07-06 |
| Heteroaryl Amide Compounds As Sting Activators App 20210163493 - Wu; Liangxing ; et al. | 2021-06-03 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 11,014,923 - Lu , et al. May 25, 2 | 2021-05-25 |
| Tricyclic heteroaryl compounds as STING activators Grant 11,008,344 - Wu , et al. May 18, 2 | 2021-05-18 |
| Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors App 20210139485 - Wang; Xiaozhao ; et al. | 2021-05-13 |
| Heterocyclic Compounds As Immunomodulators App 20210115068 - Wu; Liangxing ; et al. | 2021-04-22 |
| Heterocyclic Compounds As Immunomodulators App 20210115025 - Yu; Zhiyong ; et al. | 2021-04-22 |
| Bicyclic Amines As Cdk2 Inhibitors App 20210107901 - Ye; Yingda ; et al. | 2021-04-15 |
| Heterocyclic Compounds As Immunomodulators App 20210107900 - Wu; Liangxing ; et al. | 2021-04-15 |
| Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors Grant 10,968,221 - Wu , et al. April 6, 2 | 2021-04-06 |
| Pyrido[3,2-d]pyrimidine Compounds As Immunomodulators App 20210094976 - Li; Jingwei ; et al. | 2021-04-01 |
| Bicyclic heterocycles as FGFR inhibitors Grant 10,947,230 - Sun , et al. March 16, 2 | 2021-03-16 |
| Tricyclic heterocyclic compounds as sting activators Grant 10,947,227 - Wu , et al. March 16, 2 | 2021-03-16 |
| Imidazolyl Pyrimidinylamine Compounds As Cdk2 Inhibitors App 20210047294 - Ye; Qinda ; et al. | 2021-02-18 |
| Cyclopropylamines As Lsd1 Inhibitors App 20210032244 - Wu; Liangxing ; et al. | 2021-02-04 |
| Heterocyclic compounds as immunomodulators Grant 10,906,920 - Wu , et al. February 2, 2 | 2021-02-02 |
| Cyclopropylamines As Lsd1 Inhibitors App 20210024487 - Wu; Liangxing ; et al. | 2021-01-28 |
| Pyrazolyl Pyrimidinylamine Compounds As Cdk2 Inhibitors App 20210017156 - Hummel; Joshua ; et al. | 2021-01-21 |
| Heterocyclic Compounds As Immunomodulators App 20210017164 - Lu; Liang ; et al. | 2021-01-21 |
| Heterocyclic Compounds As Immunomodulators App 20210017175 - Li; Zhenwu ; et al. | 2021-01-21 |
| Heterocyclic Compounds As Immunomodulators App 20210002276 - Wu; Liangxing ; et al. | 2021-01-07 |
| Heterocyclic Compounds As Immunomodulators App 20200407357 - Lajkiewicz; Neil ; et al. | 2020-12-31 |
| Heteroaryl amide compounds as sting activators Grant 10,875,872 - Wu , et al. December 29, 2 | 2020-12-29 |
| Immunomodulator Compounds And Methods Of Use App 20200397893 - Liu; Phillip C. ; et al. | 2020-12-24 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20200399267 - Lu; Liang ; et al. | 2020-12-24 |
| Sulfonylamide Compounds As Cdk2 Inhibitors App 20200399273 - Sokolsky; Alexander ; et al. | 2020-12-24 |
| Heterocyclic Compounds As Lsd1 Inhibitors App 20200392143 - He; Chunhong ; et al. | 2020-12-17 |
| Pyrrolo[2,3-d]pyrimidinone Compounds As Cdk2 Inhibitors App 20200392139 - Sokolsky; Alexander ; et al. | 2020-12-17 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20200377504 - Wu; Liangxing ; et al. | 2020-12-03 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,851,105 - Wu , et al. December 1, 2 | 2020-12-01 |
| Tricyclic Amine Compounds As Cdk2 Inhibitors App 20200347067 - Ye; Qinda ; et al. | 2020-11-05 |
| Tricyclic Amine Compounds As Cdk2 Inhibitors App 20200347066 - Ye; Qinda ; et al. | 2020-11-05 |
| Heterocyclic Compounds As Immunomodulators App 20200325115 - Wu; Liangxing ; et al. | 2020-10-15 |
| Heterocyclic compounds as immunomodulators Grant 10,800,768 - Wu , et al. October 13, 2 | 2020-10-13 |
| Heterocyclic compounds as LSD1 inhibitors Grant 10,800,779 - He , et al. October 13, 2 | 2020-10-13 |
| Cyclin-dependent Kinase 2 Biomarkers And Uses Thereof App 20200316064 - Ye; Min ; et al. | 2020-10-08 |
| Heterocyclic compounds as immunomodulators Grant 10,793,565 - Wu , et al. October 6, 2 | 2020-10-06 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20200306256 - Lu; Liang ; et al. | 2020-10-01 |
| Heterocyclic Compounds As Immunomodulators App 20200283423 - Yu; Zhiyong ; et al. | 2020-09-10 |
| Heterocyclic Compounds As Immunomodulators App 20200277309 - Wu; Liangxing ; et al. | 2020-09-03 |
| Heterocyclic Compounds As Immunomodulators App 20200255424 - Kind Code | 2020-08-13 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,738,048 - Lu , et al. A | 2020-08-11 |
| Cyclopropylamines as LSD1 inhibitors Grant 10,717,737 - Wu , et al. | 2020-07-21 |
| Imidazopyridazine And Imidazopyridine Compounds And Uses Thereof App 20200199131 - Pan; Jun ; et al. | 2020-06-25 |
| Heterocyclic Compounds As Immunomodulators App 20200181126 - Lu; Liang ; et al. | 2020-06-11 |
| Cyclopropylamines As Lsd1 Inhibitors App 20200181077 - Wu; Liangxing ; et al. | 2020-06-11 |
| Cyclopropylamines as LSD1 inhibitors Grant 10,676,457 - Wu , et al. | 2020-06-09 |
| Heterocyclic Compounds As Immunomodulators App 20200172533 - Wu; Liangxing ; et al. | 2020-06-04 |
| Heterocyclic Compounds As Immunomodulators App 20200172541 - Li; Zhenwu ; et al. | 2020-06-04 |
| Heterocyclic compounds as immunomodulators Grant 10,669,271 - Wu , et al. | 2020-06-02 |
| Imidazopyridines and imidazopyrazines as LSD1 inhibitors Grant 10,640,503 - Wu , et al. | 2020-05-05 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,632,126 - Sokolsky , et al. | 2020-04-28 |
| Dihydropyrido[2,3-d]pyrimidinone Compounds As Cdk2 Inhibitors App 20200115378 - Sokolsky; Alexander ; et al. | 2020-04-16 |
| Heterocyclic compounds as immunomodulators Grant 10,618,916 - Wu , et al. | 2020-04-14 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20200095244 - Sun; Yaping ; et al. | 2020-03-26 |
| Pyrazolopyrimidine Compounds And Uses Thereof App 20200095250 - Vechorkin; Oleg ; et al. | 2020-03-26 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 10,556,908 - Wu , et al. Feb | 2020-02-11 |
| Heteroaryl Amide Compounds As Sting Activators App 20200039994 - Wu; Liangxing ; et al. | 2020-02-06 |
| Tricyclic Heteraryl Compounds As Sting Activators App 20200040009 - Wu; Liangxing ; et al. | 2020-02-06 |
| Fused Pyrazine Derivatives As A2a / A2b Inhibitors App 20200031835 - Wang; Xiaozhao ; et al. | 2020-01-30 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20200024277 - Wu; Liangxing ; et al. | 2020-01-23 |
| Cyclopropylamines as LSD1 inhibitors Grant 10,513,493 - Wu , et al. Dec | 2019-12-24 |
| Fused Pyrimidine Derivatives As A2a / A2b Inhibitors App 20190375752 - Wang; Xiaozhao ; et al. | 2019-12-12 |
| Tricyclic Heterocyclic Compounds As Sting Activators App 20190359608 - Wu; Liangxing ; et al. | 2019-11-28 |
| Heterocyclic Compounds As Immunomodulators App 20190345170 - Wu; Liangxing ; et al. | 2019-11-14 |
| Heterocyclic Compounds As Immunomodulators App 20190300524 - Wu; Liangxing ; et al. | 2019-10-03 |
| Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors App 20190292188 - Wang; Xiaozhao ; et al. | 2019-09-26 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20190284187 - Wu; Liangxing ; et al. | 2019-09-19 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20190269693 - Lu; Liang ; et al. | 2019-09-05 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20190241560 - Lu; Liang ; et al. | 2019-08-08 |
| Heterocyclic Compounds As Immunomodulators App 20190225601 - Wu; Liangxing ; et al. | 2019-07-25 |
| Cyclopropylamines As Lsd1 Inhibitors App 20190211014 - Wu; Liangxing ; et al. | 2019-07-11 |
| Heterocyclic Compounds As Immunomodulators App 20190202824 - Wu; Liangxing ; et al. | 2019-07-04 |
| Heterocyclic compounds as immunomodulators Grant 10,308,644 - Wu , et al. | 2019-06-04 |
| Cyclopropylamines as LSD1 inhibitors Grant 10,300,051 - Wu , et al. | 2019-05-28 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20190152976 - Wu; Liangxing ; et al. | 2019-05-23 |
| Heterocyclic Compounds As Immunomodulators App 20190144439 - Wu; Liangxing ; et al. | 2019-05-16 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20190127376 - Wu; Liangxing ; et al. | 2019-05-02 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20190119272 - Wu; Liangxing ; et al. | 2019-04-25 |
| Imidazopyrazines As Lsd1 Inhibitors App 20190106426 - Wu; Liangxing ; et al. | 2019-04-11 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,251,892 - Sokolsky , et al. | 2019-04-09 |
| Heterocyclic Compounds As Immunomodulators App 20190071439 - Li; Zhenwu ; et al. | 2019-03-07 |
| Cyclopropylamines As Lsd1 Inhibitors App 20190062301 - Wu; Liangxing ; et al. | 2019-02-28 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20190062327 - Sun; Yaping ; et al. | 2019-02-28 |
| Heterocyclic Compounds As Immunomodulators App 20190062345 - Xiao; Kaijiong ; et al. | 2019-02-28 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,214,528 - Lu , et al. Feb | 2019-02-26 |
| Heterocyclic Compounds As Lsd1 Inhibitors App 20190055250 - He; Chunhong ; et al. | 2019-02-21 |
| Imidazopyridines And Imidazopyrazines As Lsd1 Inhibitors App 20190040058 - Wu; Liangxing ; et al. | 2019-02-07 |
| Heterocyclic Compounds As Immunomodulators App 20190040082 - Xiao; Kaijiong ; et al. | 2019-02-07 |
| Cyclopropylamines as LSD1 inhibitors Grant 10,174,030 - Wu , et al. J | 2019-01-08 |
| Triazolopyridines and triazolopyrazines as LSD1 inhibitors Grant 10,138,249 - Wu , et al. Nov | 2018-11-27 |
| Substituted tricyclic compounds as FGFR inhibitors Grant 10,131,667 - Wu , et al. November 20, 2 | 2018-11-20 |
| Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors Grant 10,125,133 - Wu , et al. November 13, 2 | 2018-11-13 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 10,112,950 - Wu , et al. October 30, 2 | 2018-10-30 |
| Heterocyclic Compounds As Immunomodulators App 20180273519 - Wu; Liangxing ; et al. | 2018-09-27 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20180244672 - Lu; Liang ; et al. | 2018-08-30 |
| Imidazopyridines and imidazopyrazines as LSD1 inhibitors Grant 10,047,086 - Wu , et al. August 14, 2 | 2018-08-14 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,016,438 - Lu , et al. July 10, 2 | 2018-07-10 |
| Heterocyclic Compounds As Immunomodulators App 20180179197 - Wu; Liangxing ; et al. | 2018-06-28 |
| Heterocyclic Compounds As Immunomodulators App 20180179202 - Wu; Liangxing ; et al. | 2018-06-28 |
| Heterocyclic Compounds As Immunomodulators App 20180177784 - Wu; Liangxing ; et al. | 2018-06-28 |
| Immunomodulator Compounds And Methods Of Use App 20180177870 - Liu; Phillip C. ; et al. | 2018-06-28 |
| Heterocyclic Compounds As Immunomodulators App 20180179201 - Wu; Liangxing ; et al. | 2018-06-28 |
| Heterocyclic Compounds As Immunomodulators App 20180179179 - Wu; Liangxing ; et al. | 2018-06-28 |
| Cyclopropylamines as LSD1 inhibitors Grant 9,994,546 - Wu , et al. June 12, 2 | 2018-06-12 |
| Heterocyclic compounds as LSD1 inhibitors Grant 9,944,647 - He , et al. April 17, 2 | 2018-04-17 |
| Heterocyclic Compounds As Immunomodulators App 20180057486 - Wu; Liangxing ; et al. | 2018-03-01 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 9,890,156 - Lu , et al. February 13, 2 | 2018-02-13 |
| Heterocyclic Compounds As Immunomodulators App 20180016260 - Yu; Zhiyong ; et al. | 2018-01-18 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20180008610 - Lu; Liang ; et al. | 2018-01-11 |
| Imidazopyridines And Imidazopyrazines As Lsd1 Inhibitors App 20170369487 - Wu; Liangxing ; et al. | 2017-12-28 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20170369488 - Wu; Liangxing ; et al. | 2017-12-28 |
| Imidazopyrazines As Lsd1 Inhibitors App 20170369497 - Wu; Liangxing ; et al. | 2017-12-28 |
| Heterocyclic Compounds As Immunomodulators App 20170362253 - Xiao; Kaijiong ; et al. | 2017-12-21 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20170362245 - Wu; Liangxing ; et al. | 2017-12-21 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170342070 - Wu; Liangxing ; et al. | 2017-11-30 |
| Heterocyclic Compounds As Immunomodulators App 20170342060 - Lu; Liang ; et al. | 2017-11-30 |
| Heterocyclic Compounds As Immunomodulators App 20170320875 - Li; Zhenwu ; et al. | 2017-11-09 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20170320877 - Wu; Liangxing ; et al. | 2017-11-09 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 9,801,889 - Lu , et al. October 31, 2 | 2017-10-31 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20170290839 - Lu; Liang ; et al. | 2017-10-12 |
| Triazolopyridines and triazolopyrazines as LSD1 inhibitors Grant 9,758,523 - Wu , et al. September 12, 2 | 2017-09-12 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 9,708,318 - Lu , et al. July 18, 2 | 2017-07-18 |
| Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors Grant 9,695,167 - Wu , et al. July 4, 2 | 2017-07-04 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 9,695,180 - Wu , et al. July 4, 2 | 2017-07-04 |
| Substituted imidazo[1,5-.alpha.]pyridines and imidazo[1,5-.alpha.]pyrazines as LSD1 inhibitors Grant 9,695,168 - Wu , et al. July 4, 2 | 2017-07-04 |
| Heterocyclic Compounds As Immunomodulators App 20170174671 - Wu; Liangxing ; et al. | 2017-06-22 |
| Heterocyclic Compounds As Immunomodulators App 20170174679 - Lajkiewicz; Neil ; et al. | 2017-06-22 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20170166564 - Sun; Yaping ; et al. | 2017-06-15 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170158633 - Wu; Liangxing ; et al. | 2017-06-08 |
| Cyclopropylamines as LSD1 inhibitors Grant 9,670,210 - Wu , et al. June 6, 2 | 2017-06-06 |
| Heterocyclic Compounds As Immunomodulators App 20170145025 - Li; Jingwei ; et al. | 2017-05-25 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20170137424 - Wu; Liangxing ; et al. | 2017-05-18 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170121302 - Wu; Liangxing ; et al. | 2017-05-04 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20170119782 - Lu; Liang ; et al. | 2017-05-04 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170112816 - Wu; Liangxing ; et al. | 2017-04-27 |
| Heterocyclic Compounds As Immunomodulators App 20170107216 - Wu; Liangxing ; et al. | 2017-04-20 |
| Substituted tricyclic compounds as FGFR inhibitors Grant 9,611,267 - Wu , et al. April 4, 2 | 2017-04-04 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 9,580,423 - Lu , et al. February 28, 2 | 2017-02-28 |
| Bicyclic heterocycles as FGFR inhibitors Grant 9,533,984 - Sun , et al. January 3, 2 | 2017-01-03 |
| Cyclopropylamines as LSD1 inhibitors Grant 9,527,835 - Wu , et al. December 27, 2 | 2016-12-27 |
| Cyclopropylamines as LSD1 inhibitors Grant 9,493,442 - Wu , et al. November 15, 2 | 2016-11-15 |
| Cyclopropylamines as LSD1 inhibitors Grant 9,493,450 - Wu , et al. November 15, 2 | 2016-11-15 |
| Heterocyclic Compounds As Lsd1 Inhibitors App 20160289238 - He; Chunhong ; et al. | 2016-10-06 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20160244449 - Lu; Liang ; et al. | 2016-08-25 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20160244448 - Lu; Liang ; et al. | 2016-08-25 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20160244450 - Lu; Liang ; et al. | 2016-08-25 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20160115164 - Wu; Liangxing ; et al. | 2016-04-28 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20160009721 - Wu; Liangxing ; et al. | 2016-01-14 |
| Imidazopyridines And Imidazopyrazines As Lsd1 Inhibitors App 20160009712 - Wu; Liangxing ; et al. | 2016-01-14 |
| Imidazopyrazines As Lsd1 Inhibitors App 20160009720 - Wu; Liangxing ; et al. | 2016-01-14 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20160009711 - Wu; Liangxing ; et al. | 2016-01-14 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225394 - Wu; Liangxing ; et al. | 2015-08-13 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225375 - Wu; Liangxing ; et al. | 2015-08-13 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225379 - Wu; Liangxing ; et al. | 2015-08-13 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225401 - Wu; Liangxing ; et al. | 2015-08-13 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20140315902 - Sun; Yaping ; et al. | 2014-10-23 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20130338134 - Wu; Liangxing ; et al. | 2013-12-19 |
| Rosamine Derivatives As Agents For The Treatment Of Cancer App 20110212955 - Lee; Hong Boon ; et al. | 2011-09-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 